| View |
|
DRP-12388-01
|
Benzydamine Hydrochloride
|
Benzaclir
|
3 mg/mL (0.3% w/v)
|
Throat Spray (Mint Flavor)
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Interthai Pharmaceutical Manufacturing Ltd
|
Thailand
|
CLIDP Conversion
|
06 February 2024
|
29 July 2027
|
| View |
|
DRP-12389-01
|
Benzydamine (as Hydrochloride)
|
Benzaclir
|
3 mg / mL (0.3% w/v)
|
Throat Spray (Lemon Flavor)
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Interthai Pharmaceutical Manufacturing Ltd.
|
Thailand
|
CLIDP Conversion
|
15 February 2024
|
29 July 2027
|
| View |
|
DRP-12412-08
|
Losartan Potassium
|
Aceplor 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
16 January 2024
|
03 August 2025
|
| View |
|
DRP-12598-03
|
Palonosetron (as hydrochloride)
|
Palnostar
|
50 mcg/mL (250mcg/5mL)
|
Solution for Injection (IV)
|
Antiemetic/Antinauseant [Serotonin (5HT3) Anatagonist]
|
Sichuan Huiyu Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
14 February 2024
|
12 September 2027
|
| View |
|
DRP-12600-05
|
Febuxostat
|
None
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
15 February 2024
|
17 September 2027
|
| View |
|
DRP-12691-01
|
Vildagliptin
|
None
|
50 mg
|
Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 February 2024
|
22 September 2027
|
| View |
|
DRP-12735-04
|
Telmisartan + Amlodipine (as besilate)
|
Amity 80/10
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
19 January 2024
|
30 September 2027
|
| View |
|
DRP-12735-05
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 80/10
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
21 January 2024
|
30 September 2027
|
| View |
|
DRP-12735-06
|
Telmisartan + Amlodipine (as besilate)
|
Telmimore
|
80mg/10mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
21 January 2024
|
30 September 2027
|
| View |
|
DRP-12736-05
|
Telmisartan + Amlodipine (as besilate)
|
Amity 40/10
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Alu/Alu Blister Pack x 10's (Box of 30's)
|
India
|
-
|
21 January 2024
|
30 September 2027
|
| View |
|
DRP-12736-06
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 40/10
|
40 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
21 January 2024
|
30 September 2027
|
| View |
|
DRP-12737-04
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 80/5
|
80 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12737-05
|
Telmisartan + Amlodipine (as besilate)
|
Amity 80/5
|
80 mg/ 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12738-05
|
Telmisartan + Amlodipine (as besilate)
|
Amity 40/5
|
40 mg /5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12738-06
|
Telmisartan + Amlodipine (as besilate)
|
Telmimore
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12738-07
|
Telmisartan + Amlodipine (as besilate)
|
Syntam 40/5
|
40 mg /5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
23 January 2024
|
30 September 2027
|
| View |
|
DRP-12777-01
|
Ibuprofen + Paracetamol
|
Fast Relax
|
200mg/325mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)/Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
18 February 2024
|
21 October 2028
|
| View |
|
DRP-12817-02
|
Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride
|
Adivia Met
|
50 mg / 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
22 January 2024
|
29 November 2026
|
| View |
|
DRP-12905-01
|
Sitagliptin + Metformin Hydrochloride
|
Altodiab
|
50 mg/1000 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Scilife Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
15 February 2024
|
27 October 2027
|
| View |
|
DRP-12917-01
|
Cetirizine Hydrochloride
|
Cetizine
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine derivative)
|
Mercury Laboratories Ltd.
|
India
|
CLIDP Conversion
|
18 February 2024
|
28 October 2027
|